Scienture (NASDAQ:SCNX) Trading 0.9% Higher – Still a Buy?

Posted by Jessica Moore on Sep 11th, 2026

Scienture Holdings, Inc. (NASDAQ:SCNX – Get Free Report) shares traded up 0.9% on Wednesday . The company traded as high as $0.3850 and last traded at $0.3671. Approximately 8,838,234 shares traded hands during mid-day trading, an increase of 154% from the average session volume of 3,478,228 shares. The stock had previously closed at $0.3637.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a research note on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Scienture currently has a consensus rating of “Hold” and an average target price of $1.50.

View Our Latest Stock Report on Scienture

Scienture Trading Down 2.7%

The company has a fifty day moving average of $0.39 and a 200-day moving average of $0.39. The company has a current ratio of 3.04, a quick ratio of 2.97 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $14.29 million, a price-to-earnings ratio of -0.17 and a beta of 3.25.

Scienture (NASDAQ:SCNX – Get Free Report) last issued its earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.02. The business had revenue of $0.34 million during the quarter, compared to analyst estimates of $1.96 million.

Hedge Funds Weigh In On Scienture

Several large investors have recently modified their holdings of SCNX. Geode Capital Management LLC lifted its stake in Scienture by 264.3% during the fourth quarter. Geode Capital Management LLC now owns 316,201 shares of the company’s stock worth $161,000 after purchasing an additional 229,398 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Scienture in the fourth quarter valued at $46,000. Finally, Susquehanna International Group LLP purchased a new stake in shares of Scienture in the 2nd quarter valued at $82,000. Institutional investors and hedge funds own 5.68% of the company’s stock.

Scienture Company Profile

(Get Free Report)

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.